Hey everyone, I'm still getting the hang of technical analysis. What's your take on this chart purely from a technical standpoint? Do you think it's indicating a breakout or not? Are we headed to the moon or not? I'd love to hear your thoughts!
SLP: Simulations Plus, Inc.
2021-10-26 08:30:00
Simulations Plus and the University of Connecticut Awarded New FDA Contract to Accelerate the Development of Long-Acting Injectable Products
$SLP bounced nicely from 200 MA and it is currently oversold. IMO $SLP will reclaim the .382 FIB Level. This should act as support going forward.
Stop-loss and targets are given in the chart
Simulations Plus, Inc. provides modeling and simulation software and consulting services supporting drug discovery, development research, and regulatory submissions.
The financial side of the company is in good shape, according to my rating 4+ .
Technically, it is an excellent daily point in the demand zone after a false breakdown.
The potential is bombing - 15%...
SLP broke out of an extremely reliable horizontal range today. This stock is less than a year old and trades in small volumes so it may move unpredictably, ie it could be testing out the top of a new range. Any pullback to the top of the old channel looks like an excellent buy though.
SLP has a 98 rating on IBD and is in group 42.
Reasons why I like it:
- Relatively small float/mkt cap - giving it more possibility to move higher with buying
- 33% mgmt owned - run by people invested in the company, not just "care takers"
- Avg 3yr quarterly EPS 111%
- 3yr EPS growth 232%
- 3yr sales growth 43%
- Change in funds owning stock 8%
- Quarters of...
www.thestreetsweeper.org
Negative article.
Insider Selling.
This is a little copy paste from the article. Even more shady details in the article!
SLP's initial payment of $5.2 million consisted of $2.08 million in cash and over 491,000 shares ultimately valued at $3.277 million. (SLP will need to pay the remaining $720,000 cash and 170,014 issued shares in...
